Galectin‐3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in <scp>HER2</scp> ‐positive breast cancer cells-Reference-Cited by-同舟云学术

Galectin‐3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2 ‐positive breast cancer cells

Published:2022-05-22 Issue:13 Volume:13 Page:1961-1973
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Chen Yuqiu¹²,Xu Jiawei¹,Pan Wang²,Xu Xiaofan¹,Ma Xueping²,Chu Ya'nan²,Wang Lu¹,Pang Shuyun²,Li Yujiao²,Zou Bingjie³,Zhou Guohua²⁴,Gu Jun¹^ORCID

Affiliation:

1. Research Institute of General Surgery, Affiliated Jinling Hospital Medical School of Nanjing University Nanjing China

2. Department of Clinical Pharmacy, Affiliated Jinling Hospital, State Key Laboratory of Analytical Chemistry for Life Science and Jiangsu Key Laboratory of Molecular Medicine Medical School of Nanjing University Nanjing China

3. Key Laboratory of Drug Quality Control and Pharmacovigilance of Ministry of Education, School of Pharmacy China Pharmaceutical University Nanjing China

4. Department of Clinical Pharmacy, Jinling Hospital, School of Pharmacy Southern Medical University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14474

Reference52 articles.

1. Cancer Statistics, 2021

2. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy

3. HER2‐directed therapy for metastatic breast cancer;Jelovac D;Oncology (Williston Park),2013

4. Current approaches and future directions in the treatment of HER2-positive breast cancer

5. Treatment of advanced HER2-positive breast cancer: 2018 and beyond

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma;British Journal of Cancer;2024-03-04

2. Modified pectin with anticancer activity in breast cancer: A systematic review;International Journal of Biological Macromolecules;2024-01

3. Resistance of breast cancer brain metastasis to trastuzumab therapy;Overcoming Cancers Resistant to HER-2 Antibodies;2024

4. Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy;Biomarker Research;2023-02-22